Plexus Corp. (PLXS)
Why Is Plexus (PLXS) Up 12.4% Since Last Earnings Report?
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock?
Plexus Corp. (NASDAQ:PLXS) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its position in Plexus Corp. (NASDAQ:PLXS – Free Report) by 4.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 398,228 shares of the technology company’s stock after buying an additional 17,788 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.45% of Plexus worth $43,060,000 as of its most recent filing with the Securities & Exchange Commission. Several other hedge funds and other institutional investors also recently bought and sold shares of PLXS. Qube Research & Technologies Ltd increased its stake in shares of Plexus by 93.7% in the third quarter. Qube Research & Technologies Ltd now owns 22,691 shares of the technology company’s stock worth $2,110,000 after acquiring an additional 10,975 shares during the period. Avior Wealth Management LLC grew its position in Plexus by 115.2% during the 4th quarter. Avior Wealth Management LLC now owns 2,118 shares of the technology company’s stock worth $229,000 after purchasing an additional 1,134 shares during the period. Vanguard Group Inc. raised its stake in shares of Plexus by 1.4% during the 3rd quarter. Vanguard Group Inc. now owns 3,453,940 shares of the technology company’s stock valued at $321,147,000 after buying an additional 47,762 shares during the last quarter. GAMMA Investing LLC acquired a new position in shares of Plexus in the 4th quarter valued at about $44,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Plexus in the third quarter worth about $715,000. Institutional investors and hedge funds own 94.45% of the company’s stock. Insider Activity In related news, insider Steven J. Frisch sold 700 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $108.19, for a total transaction of $75,733.00. Following the completion of the sale, the insider now directly owns 56,113 shares in the company, valued at $6,070,865.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Todd P. Kelsey sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $102.10, for a total value of $102,100.00. Following the completion of the sale, the chief executive officer now directly owns 113,810 shares in the company, valued at $11,620,001. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Steven J. Frisch sold 700 shares of the stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $108.19, for a total value of $75,733.00. Following the completion of the sale, the insider now directly owns 56,113 shares of the company’s stock, valued at approximately $6,070,865.47. The disclosure for this sale can be found here. Insiders have sold a total of 33,731 shares of company stock worth $3,449,529 over the last quarter. 2.39% of the stock is currently owned by corporate insiders. Wall Street Analyst Weigh In PLXS has been the subject of several recent research reports. Needham & Company LLC lifted their price target on Plexus from $107.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, April 26th. TheStreet downgraded shares of Plexus from a “b” rating to a “c+” rating in a report on Tuesday, February 13th. Finally, Stifel Nicolaus lifted their price objective on shares of Plexus from $90.00 to $95.00 and gave the company a “hold” rating in a report on Friday, April 26th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $107.75. Get Our Latest Research Report on PLXS Plexus Trading Up 0.6 % Shares of NASDAQ:PLXS opened at $109.52 on Monday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.51 and a quick ratio of 0.64. The business’s 50 day moving average price is $97.96 and its 200-day moving average price is $99.78. The firm has a market capitalization of $3.00 billion, a price-to-earnings ratio of 30.25 and a beta of 1.00. Plexus Corp. has a 1 year low of $86.11 and a 1 year high of $114.06. Plexus (NASDAQ:PLXS – Get Free Report) last released its earnings results on Wednesday, April 24th. The technology company reported $0.94 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.07. The business had revenue of $966.90 million during the quarter, compared to analysts’ expectations of $950.75 million. Plexus had a net margin of 2.54% and a return on equity of 10.77%. The company’s quarterly revenue was down 9.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.45 earnings per share. On average, equities research analysts forecast that Plexus Corp. will post 3.81 earnings per share for the current fiscal year. Plexus Company Profile (Free Report) Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
